TrialCancer science2026

Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T.

Fumihiro Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.